Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
21 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY from Jette, company number BE0439302013, closed financial year 2025 with a result of € -462,336 after tax. For that financial year BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY recorded a gross margin of € -481,998 and equity of € 771,668. Compared with financial year 2024, the result moved from € -64,484 to € -462,336. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.
€ 771,668
▼ 37% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -462,336
▼ 617 % more loss than in 2024
Profit after tax over the fiscal year.
€ 140,881
▼ 17% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
€ 2,503
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 123,784
▲ € 104,368 vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 336,875 | - | - | - | |
| Gross margin | € 78,292 | € -173,544 | € -138,560 | € -481,998 | ▼ € 343,437 |
| Profit after taxes | € -60,118 | € -115,082 | € -64,484 | € -462,336 | ▼ € 397,852 |
| Equity | € 1,413,569 | € 1,298,487 | € 1,234,003 | € 771,668 | ▼ 37% |
| Total debts | € 46,816 | € 28,765 | € 24,248 | € 123,784 | ▲ € 99,536 |
| Cash | € 327,608 | € 137,675 | € 169,241 | € 140,881 | ▼ 17% |
| Retained profit | € 1,413,569 | € 1,298,487 | € 1,234,003 | € 771,668 | ▼ 37% |
| Balance sheet total | € 1,460,385 | € 1,327,252 | € 1,258,251 | € 895,452 | ▼ 29% |
Key figures of BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY?
What happened at BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 462,336. Source: NBB ↗
- Daniel Klink became a director. NBB
- Elise Nauwynck became a director. NBB
- Philippe Lysy stepped down as director. NBB
- Marianne Becker stepped down as director. NBB
- Start of the company according to the CBE. KBO
In short
From € 60,118 loss in 2022 to € 462,336 loss in 2025.
Paid € 23,577 in corporate taxes since 2022.
A new publication or filing at BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY? We notify you, reason included.
Follow BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGYDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY are Jean De Schepper, Daniel Klink and Elise Nauwynck. Daniel Klink is also behind KLINK MEDICAL SERVICES.
Directors
According to the 2025 annual accounts
Jean De Schepper
Director
since 2025
Elise Nauwynck
Director
since 2025
Philippe Lysy
Director
· until 2025
Marianne Becker
Director
· until 2025
Establishments
Establishment units
Physical locations of this company
Laarbeeklaan 101
1090 Jette
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 21 companies are registered at this address.
All companies at this address →Belgische Vereniging voor Orthopedie en Traumatologie
BELGISCH HOOFDPIJNGENOOTSCHAP
The Toxicological Society of Belgium and Luxembourg
belgian society of pediatric gastroenterology hepatology and nutrition
Belgian Diabetes Registry
+16 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0439.302.013
- VAT number
- BE 0439.302.013
- Registered office
- Laarbeeklaan 101, 1090 Jette
- Names & denominations
- BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY · Belgian and Luxemburgish Society for Pediatric Endocrinology and Diabetology · BELSPEED
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 28 February 1989
- Peppol
- Active · Active since 22 Nov 2025
- Activities · NACE
Activiteiten op het gebied van voeding
Overige menselijke gezondheidszorg, n.e.g.